Overview
No overview information available.
Indication
用于急、慢性肝炎，白细胞减少症，血小板减少症及再生障碍性贫血等的辅助治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/12/24 | N/A | Recruiting | Xiangya Hospital of Central South University | ||
2024/06/11 | Phase 1 | Not yet recruiting | |||
2022/01/24 | Phase 1 | UNKNOWN | |||
2020/07/10 | Phase 2 | Terminated | |||
2018/12/11 | Not Applicable | Recruiting | Sun Yat-sen University | ||
2005/08/10 | Phase 2 | Completed | Tibotec Pharmaceuticals, Ireland |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Sodium Deoxyribonucleotide Injection | 国药准字H11022106 | 化学药品 | 注射剂(小容量注射剂) | 10/16/2020 | |
| Sodium Deoxyribonucleotide for Injection | 国药准字H20054475 | 化学药品 | 注射剂 | 8/14/2020 | |
| Sodium Deoxyribonucleotide Tablets | 国药准字H31022550 | 化学药品 | 片剂(薄膜衣) | 12/19/2019 | |
| Sodium Deoxyribonucleotide Tablets | 国药准字H33021972 | 化学药品 | 片剂 | 5/9/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.